CN100339111C - 一种治疗冠心病的药物及其制备方法 - Google Patents
一种治疗冠心病的药物及其制备方法 Download PDFInfo
- Publication number
- CN100339111C CN100339111C CNB2005100993123A CN200510099312A CN100339111C CN 100339111 C CN100339111 C CN 100339111C CN B2005100993123 A CNB2005100993123 A CN B2005100993123A CN 200510099312 A CN200510099312 A CN 200510099312A CN 100339111 C CN100339111 C CN 100339111C
- Authority
- CN
- China
- Prior art keywords
- medicine
- treatment
- radix
- carapax
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 21
- 229940079593 drug Drugs 0.000 title description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 11
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000190633 Cordyceps Species 0.000 claims description 13
- 210000001320 hippocampus Anatomy 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 210000003038 endothelium Anatomy 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000005498 polishing Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 2
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 abstract 1
- 241001523681 Dendrobium Species 0.000 abstract 1
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 abstract 1
- 241001559542 Hippocampus hippocampus Species 0.000 abstract 1
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 abstract 1
- 244000118681 Iresine herbstii Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 23
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 206010061876 Obstruction Diseases 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000000115 thoracic cavity Anatomy 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 206010063659 Aversion Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000018927 edible plant Nutrition 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000019775 Back disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
症状 | 治疗组 | 对照组 | ||
治疗前 | 治疗后 | 治疗前 | 治疗后 | |
(例)X±SD | (例)X±SD | (例)X±SD | (例)X±SD | |
心悸 | (48)1.97±0.58 | 0.78±0.44* | (19)2.01±0.44 | 1.24±0.21△ |
气短 | (49)2.23±0.49 | 0.93±0.34* | (23)2.04±0.39 | 1.02±0.11*△ |
胸痛 | (36)1.81±0.64 | 0.73±0.27* | (19)2.08±0.45 | 1.98±0.32△ |
胸闷 | (41)2.21±0.47 | 0.85±0.40* | (25)1.98±0.21 | 0.32±0.14△ |
神疲乏力 | (44)2.46±0.39 | 0.83±0.35* | (12)2.11±0.14 | 2.01±0.12△ |
头晕目花 | (45)1.57±0.45 | 1.01±0.33 | (6)1.24±0.21 | 0.64±0.19* |
腰膝酸软 | (34)2.25±0.46 | 0.82±0.34* | (14)2.09±0.11 | 0.94±0.16*△ |
畏寒肢冷 | (41)2.02±0.68 | 0.68±0.32* | (17)1.98±0.34 | 0.92±0.15△ |
自汗 | (37)1.76±0.21 | 0.87±0.11* | (19)1.90±0.11 | 1.02±0.17△ |
失眠 | (32)1.53±0.46 | 0.63±0.49* | (13)0.98±0.15 | 0.84±0.16△ |
健忘 | (37)2.03±0.36 | 1.34±0.39* | (8)2.85±0.17 | 2.04±0.16△ |
部平均积分值 | 21.84±6.01 | 9.47±5.36 | 21.26±5.95 | 13.97±4.56△ |
*自身比较P<0.01 △组间比较P<0.05 |
组别 | 舌 | 脉 | ||
好转% | 无效% | 好转% | 无效% | |
治疗组 | 21(51.22) | 20(48.78) | 25(55.56) | 20(44.44) |
对照组 | 7(35.00) | 13(65.00) | 7(36.84) | 12(63.16) |
Ridit检验 舌脉P>0.05 |
组别 | 例数 | 总胆固醇 | 甘油三脂 | β-脂蛋白 | |||
治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | ||
治疗组 | 60 | 276±13.40 | 180±11.729** | 186±10.97 | 134±13.25 | 712±146.30 | 560±131.20* |
对照组 | 30 | 276±14.24 | 250±11.01^ | 181±10.08 | 180±92.0*△ | 712±149.61 | 691±141.40△ |
自身比较 **P<0.01 *P<0.05 组间比较 △P<0.5 |
组别 | 例数 | 全血粘度(低切) | 血浆粘度比 | 血细胞压积(%) | 纤维蛋白原mg/dv |
治疗组 | 57 | 药前10.35±0.31 | 1.88±0.06 | 47.65±10.00 | 523.7±43.00 |
药后7.3±0.42* | 1.58±0.07* | 45.10±11.40 | 433.9±470*△ | ||
对照组 | 25 | 药前11.52±0.36 | 1.86±0.04 | 46.30±12.00 | 575±31.00 |
药后5.20±0.24*△ | 1.81±0.03△ | 47.6±13.40 | 584±35.0△ | ||
自身比较 P<0.01组间比较P<0.05 |
组别 | 例数 | 轻度 | 中度 | 重度 | ||||||
显效(%) | 有效(%) | 无效(%) | 显效(%) | 有效(%) | 无效(%) | 显效(%) | 有效(%) | 无效(%) | ||
治疗组 | 60 | 5(313) | 8(50.00) | 3(18.75) | 8(25.80) | 17(54.84) | 6(19.36) | 4(30.77) | 7(53.85) | 2(15.39) |
对照组 | 30 | 1(20.00) | 2(40.00) | 2(40.00) | 1(14.29) | 4(57.14) | 2(28.57) | 5(27.77) | 8(44.44) | 5(16.40) |
组别 | 例 | 显效(%) | 有效(%) | 无效(%) | 加重(%) | 总有效率(%) |
治疗组 | 60 | 19(31.67) | 36(60.00) | 5(8.33) | 0(0.00) | 91.67 |
对照组 | 30 | 5(16.67) | 15(50.00) | 9(30.00) | 1(3.33) | 66.67 |
两组总有效率经Ridit检验P<0.01 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100993123A CN100339111C (zh) | 2005-09-13 | 2005-09-13 | 一种治疗冠心病的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100993123A CN100339111C (zh) | 2005-09-13 | 2005-09-13 | 一种治疗冠心病的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1739741A CN1739741A (zh) | 2006-03-01 |
CN100339111C true CN100339111C (zh) | 2007-09-26 |
Family
ID=36092366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100993123A Active CN100339111C (zh) | 2005-09-13 | 2005-09-13 | 一种治疗冠心病的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100339111C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129469B (zh) * | 2007-03-05 | 2010-09-29 | 厦门金日制药有限公司 | 防治心脑血管疾病的中药组合物 |
CN101850066B (zh) * | 2009-11-06 | 2012-02-08 | 中山市中智中药饮片有限公司 | 中药组合物颗粒剂及其制备方法 |
CN106421408A (zh) * | 2016-12-15 | 2017-02-22 | 同溢堂药业有限公司 | 一种用于治疗难治性心衰的药物组合物 |
CN108210743A (zh) * | 2016-12-20 | 2018-06-29 | 广东伊茗药业有限公司 | 一种益肝宁神的药物组合物及其制备方法 |
CN107970376A (zh) * | 2017-10-28 | 2018-05-01 | 王高 | 一种治疗心脑血管疾病的中药组合物 |
CN110585345A (zh) * | 2018-11-20 | 2019-12-20 | 林录华 | 一种治疗心脑血管疾病的中药 |
CN112546157A (zh) * | 2021-01-14 | 2021-03-26 | 陈自智 | 综合施治心脑血管病的中药及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1305844A (zh) * | 2001-01-14 | 2001-08-01 | 刘红 | 用于治疗充血性心力衰竭的药物 |
-
2005
- 2005-09-13 CN CNB2005100993123A patent/CN100339111C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1305844A (zh) * | 2001-01-14 | 2001-08-01 | 刘红 | 用于治疗充血性心力衰竭的药物 |
Non-Patent Citations (1)
Title |
---|
冠心病心绞痛中医治疗法则及其疗效原理研究进展(续) 何熹延等,中医药信息,第4期 1997 * |
Also Published As
Publication number | Publication date |
---|---|
CN1739741A (zh) | 2006-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100339111C (zh) | 一种治疗冠心病的药物及其制备方法 | |
CN101062080A (zh) | 一种具有抗疲劳作用的药物组合物及其制备方法 | |
CN101053621A (zh) | 一种治疗肥胖症的中药组合物及其制备方法 | |
CN102949521A (zh) | 一种用于缓解体力疲劳的纯中药保健品及其制备方法 | |
CN108524776A (zh) | 一种治疗气阴两虚型糖尿病的药物及其制备方法 | |
CN101234170A (zh) | 一种三味生脉注射液及其制备方法 | |
CN101073409A (zh) | 药食多效保健品 | |
CN115040612A (zh) | 一种调理高血压的组合物及其制备方法 | |
CN1895593A (zh) | 一种治疗痤疮的药物及其制备方法 | |
CN1063649C (zh) | 一种红参山楂保健酒 | |
CN1239194C (zh) | 一种用于治疗冠心病心绞痛的中成药 | |
CN1183936C (zh) | 一种治疗高血压病的药物及其茶剂制备方法 | |
CN112451608A (zh) | 一种具有“骨肾同治”效应的补肾温阳通络方 | |
CN112089784A (zh) | 中药组合物在制备预防、治疗动脉粥样硬化所致疾病的药物中的应用 | |
CN1695715A (zh) | 一种治疗血管性痴呆的药物及其制备方法 | |
CN100574799C (zh) | 人参四逆注射剂及制备方法 | |
CN1528430A (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 | |
CN1265829C (zh) | 一种能预防、治疗心脑血管疾病的保健食品 | |
CN1242801C (zh) | 一种治疗冠心病心绞痛的药物组合物及其制备方法 | |
CN1628829A (zh) | 一种治疗高血压高血脂高血糖的中药 | |
CN1895503A (zh) | 一种鹿茸胶囊 | |
CN1679908A (zh) | 一种治疗肿瘤的中药及其制备方法 | |
CN101066327A (zh) | 功能性养生酒及其制备工艺 | |
CN1079658A (zh) | 用于治疗慢性缺血性心脏病的一种中药散剂胶囊 | |
CN105147861A (zh) | 一种用于治疗病毒性皮肤病的中药组合物、口服剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine for curing coronary artery disease and its preparation method Effective date of registration: 20180413 Granted publication date: 20070926 Pledgee: Bank of China, Limited by Share Ltd Zhangpu branch Pledgor: Tongyitang Pharmaceutical Co., Ltd. Registration number: 2018350000032 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190412 Granted publication date: 20070926 Pledgee: Bank of China Limited by Share Ltd Zhangpu branch Pledgor: Tongyitang Pharmaceutical Co., Ltd. Registration number: 2018350000032 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine for curing coronary artery disease and its preparation method Effective date of registration: 20190418 Granted publication date: 20070926 Pledgee: Bank of China Limited by Share Ltd Zhangpu branch Pledgor: Tongyitang Pharmaceutical Co., Ltd. Registration number: 2019350000040 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200825 Granted publication date: 20070926 Pledgee: Bank of China Limited by Share Ltd. Zhangpu branch Pledgor: TONGYITANG PHARMACEUTICAL Co.,Ltd. Registration number: 2019350000040 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A drug for treating coronary heart disease and its preparation method Effective date of registration: 20200828 Granted publication date: 20070926 Pledgee: Bank of China Limited by Share Ltd. Zhangpu branch Pledgor: TONGYITANG PHARMACEUTICAL Co.,Ltd. Registration number: Y2020350000102 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210924 Granted publication date: 20070926 Pledgee: Bank of China Limited by Share Ltd. Zhangpu branch Pledgor: TONGYITANG PHARMACEUTICAL Co.,Ltd. Registration number: Y2020350000102 |